{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T01:04:50Z","timestamp":1794877490437,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4432-4","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T12:36:44Z","timestamp":1525351004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin\u2019s lymphoma"],"prefix":"10.1186","volume":"18","author":[{"given":"Julian M. M.","family":"Rogasch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Hundsdoerfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Hofheinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Wedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imke","family":"Schatka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Amthauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Furth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"key":"4432_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3322\/caac.21219","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64:83\u2013103.","journal-title":"CA Cancer J Clin"},{"key":"4432_CR2","unstructured":"First International Inter-Group Study for Classical Hodgkin\u2019s Lymphoma in Children and Adolescents. Final protocol version, 6th amendment. ClinicalTrials.gov Identifier: NCT00433459. https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT00433459 . Accessed 03 Nov 2017."},{"key":"4432_CR3","unstructured":"Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents. Final protocol version, 1st amendment. NCT02684708. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02684708 . Accessed 03 Nov 2017."},{"key":"4432_CR4","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1007\/s00259-010-1490-5","volume":"37","author":"SF Barrington","year":"2010","unstructured":"Barrington SF, Qian W, Somer EJ, Franceschetto A, Bagni B, Brun E, et al. Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging. 2010;37:1824\u201333.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4432_CR5","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1200\/JCO.2008.19.7814","volume":"27","author":"C Furth","year":"2009","unstructured":"Furth C, Steffen IG, Amthauer H, Ruf J, Misch D, Sch\u00f6nberger S, et al. Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin\u2019s lymphoma: analysis of a prospective multicenter trial. J Clin Oncol. 2009;27:4385\u201391.","journal-title":"J Clin Oncol"},{"key":"4432_CR6","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00259-014-2715-9","volume":"41","author":"D Hasenclever","year":"2014","unstructured":"Hasenclever D, Kurch L, Mauz-K\u00f6rholz C, Elsner A, Georgi T, Wallace H, et al. qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma. Eur J Nucl Med Mol Imaging. 2014;41:1301\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4432_CR7","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/annonc\/mdq557","volume":"22","author":"C Furth","year":"2011","unstructured":"Furth C, Amthauer H, Hautzel H, Steffen IG, Ruf J, Schiefer J, et al. Evaluation of interim PET response criteria in paediatric Hodgkin's lymphoma--results for dedicated assessment criteria in a blinded dual-Centre read. Ann Oncol. 2011;22:1198\u2013203.","journal-title":"Ann Oncol"},{"key":"4432_CR8","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1200\/JCO.2003.11.059","volume":"21","author":"S Bhatia","year":"2003","unstructured":"Bhatia S, Yasui Y, Robinson LL, Birch JM, Bogue MK, Diller L, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin\u2019s disease: report from the late effects study group. J Clin Oncol. 2003;21:4386\u201394.","journal-title":"J Clin Oncol"},{"key":"4432_CR9","doi-asserted-by":"publisher","unstructured":"Morton LM, Onel K, Curtis RE, Hungate EA, Armstrong GT. The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults. Am Soc Clin Oncol Educ Book. 2014:e57-e67; doi: https:\/\/doi.org\/10.14694\/EdBook_AM.2014.34.e57 .","DOI":"10.14694\/EdBook_AM.2014.34.e57"},{"key":"4432_CR10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2967\/jnumed.116.176511","volume":"58","author":"S Bakhshi","year":"2017","unstructured":"Bakhshi S, Bhethanabhotla S, Kumar R, Agarwal K, Sharma P, Thulkar S, et al. Posttreatment PET\/CT rather than interim PET\/CT using deauville criteria predicts outcome in pediatric hodgkin lymphoma: a prospective study comparing PET\/CT with conventional imaging. J Nucl Med. 2017;58:577\u201383.","journal-title":"J Nucl Med"},{"key":"4432_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00259-012-2293-7","volume":"40","author":"S Punwani","year":"2013","unstructured":"Punwani S, Taylor SA, Saad ZZ, Bainbridge A, Groves A, Daw S, et al. Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET\/MRI? Eur J Nucl Med Mol Imaging. 2013;40:373\u201385.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4432_CR12","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1200\/JCO.2016.66.9440","volume":"34","author":"M Meignan","year":"2016","unstructured":"Meignan M, Cottereau AS, Versari A, Chartier L, Dupuis J, Boussetta S, et al. Baseline metabolic tumor volume predicts outcome in high-tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies. J Clin Oncol. 2016;34:3618\u201326.","journal-title":"J Clin Oncol"},{"key":"4432_CR13","doi-asserted-by":"publisher","first-page":"4608","DOI":"10.1002\/mp.12349","volume":"44","author":"F Ben Bouall\u00e8gue","year":"2017","unstructured":"Ben Bouall\u00e8gue F, Tabaa YA, Kafrouni M, Cartron G, Vauchot F, Mariano-Goulart D. Association between textural and morphological tumor indices on baseline PET-CT and early metabolic response on interim PET-CT in bulky malignant lymphomas. Med Phys. 2017;44:4608\u201319.","journal-title":"Med Phys"},{"key":"4432_CR14","unstructured":"Dosage card Version 5.7.2016. European Association of Nuclear Medicine. http:\/\/www.eanm.org\/content-eanm\/uploads\/2017\/01\/EANM_Dosage_Card_040214.pdf . Accessed 27 Oct 2017."},{"key":"4432_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3413\/Nukmed-0419-11-07","volume":"51","author":"F Hofheinz","year":"2012","unstructured":"Hofheinz F, Poetzsch C, Oehme L, Beuthien-Baumann B, Steinbach J, Kotzerke J, et al. Automatic volume delineation in oncological PET. Evaluation of a dedicated software tool and comparison with manual delineation in clinical data sets. Nuklearmedizin. 2012;51:9\u201316.","journal-title":"Nuklearmedizin"},{"key":"4432_CR16","doi-asserted-by":"publisher","first-page":"082503","DOI":"10.1118\/1.4812892","volume":"40","author":"F Hofheinz","year":"2013","unstructured":"Hofheinz F, Langner J, Petr J, Beuthien-Baumann B, Steinbach J, Kotzerke J, et al. An automatic method for accurate volume delineation of heterogeneous tumors in PET. Med Phys. 2013;40:082503. https:\/\/doi.org\/10.1118\/1.4812892 .","journal-title":"Med Phys"},{"key":"4432_CR17","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s00330-014-3269-8","volume":"24","author":"I Apostolova","year":"2014","unstructured":"Apostolova I, Steffen IG, Wedel F, Lougovski A, Marnitz S, Derlin T, et al. Asphericity of pretherapeutic tumor FDG uptake provides independent prognostic value in head-and-neck cancer. Eur Radiol. 2014;24:2077\u201387.","journal-title":"Eur Radiol"},{"key":"4432_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00259-014-2953-x","volume":"42","author":"F Hofheinz","year":"2015","unstructured":"Hofheinz F, Lougovski A, Z\u00f6phel K, Hentschel M, Steffen IG, Apostolova I, et al. Increased evidence for the prognostic value of primary tumor asphericity in pretherapeutic FDG PET for risk stratification in patients with head and neck cancer. Eur J Nucl Med Mol Imaging. 2015;42:429\u201337.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4432_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2967\/jnumed.114.144055","volume":"56","author":"M Hatt","year":"2015","unstructured":"Hatt M, Majdoub M, Valli\u00e8res M, Tixier F, Le Rest CC, Groheux D, et al. 18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort. J Nucl Med. 2015;56:38\u201344.","journal-title":"J Nucl Med"},{"key":"4432_CR20","doi-asserted-by":"publisher","first-page":"5471","DOI":"10.1088\/0031-9155\/60\/14\/5471","volume":"60","author":"M Valli\u00e8res","year":"2015","unstructured":"Valli\u00e8res M, Freeman CR, Skamene SR, El Naqa I. A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities. Phys Med Biol. 2015;60:5471\u201396.","journal-title":"Phys Med Biol"},{"key":"4432_CR21","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.patcog.2008.08.011","volume":"42","author":"I El Naqa","year":"2009","unstructured":"El Naqa I, Grigsby P, Apte A, Kidd E, Donnelly E, Khullar D, et al. Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recogn. 2009;42:1162\u201371.","journal-title":"Pattern Recogn"},{"key":"4432_CR22","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1007\/s00259-011-1845-6","volume":"38","author":"FH van Velden","year":"2011","unstructured":"van Velden FH, Cheebsumon P, Yaqub M, Smit EF, Hoekstra OS, Lammertsma AA, et al. Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies. Eur J Nucl Med Mol Imaging. 2011;38:1636\u201347.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4432_CR23","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.hoc.2007.06.011","volume":"21","author":"BD Cheson","year":"2007","unstructured":"Cheson BD. The international harmonization project for response criteria in lymphoma clinical trials. Hematol Oncol Clin North Am. 2007;21:841\u201354.","journal-title":"Hematol Oncol Clin North Am"},{"key":"4432_CR24","doi-asserted-by":"publisher","unstructured":"Cottereau AS, El-Galaly TC, Becker S, Broussais F, Peterson LJ, Bonnet C, et al. Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients. J Nucl Med. 2017. https:\/\/doi.org\/10.2967\/jnumed.117.193946 . [Epub ahead of print].","DOI":"10.2967\/jnumed.117.193946"},{"key":"4432_CR25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2967\/jnumed.116.180406","volume":"58","author":"AS Cottereau","year":"2017","unstructured":"Cottereau AS, Hapdey S, Chartier L, Modzelewski R, Casasnovas O, Itti E, et al. Baseline total metabolic tumor volume measured with fixed or different adaptive thresholding methods equally predicts outcome in peripheral T cell lymphoma. J Nucl Med. 2017;58:276\u201381.","journal-title":"J Nucl Med"},{"key":"4432_CR26","doi-asserted-by":"publisher","first-page":"e0140830","DOI":"10.1371\/journal.pone.0140830","volume":"10","author":"S Kanoun","year":"2015","unstructured":"Kanoun S, Tal I, Berriolo-Riedinger A, Rossi C, Riedinger JM, Vrigneaud JM, et al. Influence of software tool and methodological aspects of total metabolic tumor volume calculation on baseline [18F] FDG PET to predict survival in hodgkin lymphoma. PLoS One. 2015;10:e0140830. https:\/\/doi.org\/10.1371\/journal.pone.0140830 . eCollection 2015.","journal-title":"PLoS One"},{"key":"4432_CR27","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.ijrobp.2004.06.254","volume":"60","author":"QC Black","year":"2004","unstructured":"Black QC, Grills IS, Kestin LL, Wong CY, Wong JW, Martinez AA, et al. Defining a radiotherapy target with positron emission tomography. Int J Radiat Oncol Biol Phys. 2004;60:1272\u201382.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4432_CR28","first-page":"1519","volume":"45","author":"R Boellaard","year":"2004","unstructured":"Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med. 2004;45:1519\u201327.","journal-title":"J Nucl Med"},{"key":"4432_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0167-8140(03)00270-6","volume":"69","author":"JF Daisne","year":"2003","unstructured":"Daisne JF, Sibomana M, Bol A, Doumont T, Lonneux M, Gregoire V. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. Radiother Oncol. 2003;69:247\u201350.","journal-title":"Radiother Oncol"},{"key":"4432_CR30","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1118\/1.2198308","volume":"33","author":"L Drever","year":"2006","unstructured":"Drever L, Robinson DM, McEwan A, Roa W. A local contrast based approach to threshold segmentation for PET target volume delineation. Med Phys. 2006;33:1583\u201394.","journal-title":"Med Phys"},{"key":"4432_CR31","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12+<2505::AID-CNCR24>3.0.CO;2-F","volume":"80","author":"YE Erdi","year":"1997","unstructured":"Erdi YE, Mawlawi O, Larson SM, Imbriaco M, Yeung H, Finn R, et al. Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer. 1997;80:2505\u20139.","journal-title":"Cancer"},{"key":"4432_CR32","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.2967\/jnumed.110.077255","volume":"51","author":"V Frings","year":"2010","unstructured":"Frings V, de Langen AJ, Smit EF, van Velden FH, Hoekstra OS, van Tinteren H, et al. Repeatability of metabolically active volume measurements with 18F-FDG and 18F-FLT PET in non-small cell lung cancer. J Nucl Med. 2010;51:1870\u20137.","journal-title":"J Nucl Med"},{"key":"4432_CR33","first-page":"108","volume":"48","author":"W Jentzen","year":"2007","unstructured":"Jentzen W, Freudenberg L, Eising EG, Heinze M, Brandau W, Bockisch A. Segmentation of PET volumes by iterative image thresholding. J Nucl Med. 2007;48:108\u201314.","journal-title":"J Nucl Med"},{"key":"4432_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/MNM.0b013e328155d154","volume":"28","author":"JA van Dalen","year":"2007","unstructured":"van Dalen JA, Hoffmann AL, Dicken V, Vogel WW, Wiering B, Ruers TJ, et al. A novel iterative method for lesion delineation and volumetric quantification with FDG PET. Nucl Med Commun. 2007;28:485\u201393.","journal-title":"Nucl Med Commun"},{"key":"4432_CR35","doi-asserted-by":"publisher","first-page":"6901","DOI":"10.1088\/0031-9155\/54\/22\/010","volume":"54","author":"S Vauclin","year":"2009","unstructured":"Vauclin S, Doyeux K, Hapdey S, Edet-Sanson A, Vera P, Gardin I. Development of a generic thresholding algorithm for the delineation of 18FDG-PET-positive tissue: application to the comparison of three thresholding models. Phys Med Biol. 2009;54:6901\u201316.","journal-title":"Phys Med Biol"},{"key":"4432_CR36","doi-asserted-by":"publisher","first-page":"e0153281","DOI":"10.1371\/journal.pone.0153281","volume":"11","author":"JP Hwang","year":"2016","unstructured":"Hwang JP, Lim I, Kong CB, Jeon DG, Byun BH, et al. Prognostic value of SUVmax measured by pretreatment Fluorine-18 Fluorodeoxyglucose positron emission tomography\/computed tomography in patients with Ewing sarcoma. PLoS One. 2016;11:e0153281. https:\/\/doi.org\/10.1371\/journal.pone.0153281 .","journal-title":"PLoS One"},{"key":"4432_CR37","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2967\/jnumed.108.058461","volume":"50","author":"CM Costelloe","year":"2009","unstructured":"Costelloe CM, Macapinlac HA, Madewell JE, Fitzgerald NE, Mawlawi OR, Rohren EM, et al. 18F-FDG PET\/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med. 2009;50:340\u20137.","journal-title":"J Nucl Med"},{"key":"4432_CR38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1182\/blood-2017-04-773838","volume":"131","author":"M Akhtari","year":"2018","unstructured":"Akhtari M, Milgrom SA, Pinnix CC, Reddy JP, Dong W, Smith GL, et al. Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation. Blood. 2018;131:84\u201394.","journal-title":"Blood"},{"key":"4432_CR39","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","volume":"86","author":"PE Shrout","year":"1979","unstructured":"Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420\u20138.","journal-title":"Psychol Bull"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4432-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4432-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4432-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T11:05:21Z","timestamp":1571310321000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4432-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4432"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4432-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,3]]},"assertion":[{"value":"20 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study has been approved by the ethics committee (Ethikkommission der Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin; vote, EA2\/151\/16), and all subjects (or the person having the care and custody of the child) signed an informed consent form regarding the participation in the study and a consent for publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All subjects (or the person having the care and custody of the child) signed an informed consent form regarding the consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"521"}}